The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.